FMD Vaccine Development
US - The Department of Homeland Security, Science and Technology Directorate, intends to award a contract on a sole-source basis to continue developing and retool production of cell lines and master seeds for foot and mouth disease vaccine.
27 February 2009
1 minute read
The authority for this sole source award is FAR 6.302-1 - there is only one source that can provide these services and products to DHS. The contract will be awarded to Genvec, Inc. of Gaithersburg, Maryland. Genvec is the only entity capable of performing these services because it created and owns the intellectually property associated with cell lines and master seeds upon which the vaccine will be based.
Development of a new cell line and master seed is not feasible and would result in the foot and mouth disease vaccine program being set back by years. The period of performance for this requirement is one year from the date of award plus three one-year option periods. Anticipated deliverables under this contract include vaccines, augmented cell lines and master seeds, reports detailing production process streamlining, and CVB licensure.
This notice is NOT a solicitation for proposals or quotations; however, any entity that believes it has the expertise, conforming data sets, and analysis methods to perform the required services is encouraged to submit a letter via e-mail to the Contracting Officer identifying their interest in the requirement and their capabilities. The determination to compete this procurement based on responses to this notice is solely within the discretion of the Contracting Officer.
